Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 1 Therapeutic interventions for DENV infection

From: Investigating how dengue virus-induced metabolic changes affect the host immune response and how to develop Immunomodulatory strategies

Therapeutic Strategy

Key Insights

Examples/Drugs

References

Metabolic Pathway Inhibitors

Target glycolysis, lipid metabolism, amino acid metabolism and host glycoprotein processing to disrupt viral replication.

2-Deoxy-D-Glucose (2-DG), Metformin, 6-Amino-Nicotinamide (6-AN), FAS inhibitors, Celgosivir.

[48, 68, 127,128,129,130]

Drug Repurposing

Identify existing drugs that modulate immune-metabolic pathways.

Oxprenolol, Digoxin, Auranofin, Atorvastatin.

[131]

Natural Compounds

Use natural molecules with dual antiviral and anti-inflammatory effects.

Cordycepin (targets NS5 and NF-κB), Zileuton, Trimethadione, Linalool.

[132, 133]

RNA Replication Inhibitors

Target viral RNA replication mechanisms.

Sofosbuvir, JNJ-1802 (Mosnodenvir), EYU-688.

([134], NCT04906980, NCT06006559)

Host-Directed Therapies

Enhance host defenses and metabolic resilience against DENV.

Kinase inhibitors, Antioxidants, Niclosamide (nanoengineered for improved delivery).

[135, 136]

Immune Modulation

Fine-tune immune responses to reduce inflammation and enhance antiviral immunity.

Immune checkpoint inhibitors (PD-1, CTLA-4), IL-2 and IL-7 cytokines, Anti-inflammatory drugs (corticosteroids, IL-6 inhibitors).

[137,138,139,140,141]

Vaccination and Immune Priming

Develop vaccines and adjuvants targeting metabolic pathways to improve immune responses.

Next-generation vaccines (glycolysis/oxidative phosphorylation modulators), Metabolic adjuvants for DCs.

[148, 149, 157, 158]

Advanced Drug Delivery Systems

Improve delivery and bioavailability of therapeutic agents with poor solubility or stability.

Nanoengineered delivery of nucleic acid-based vaccines or repurposed drugs (e.g., Niclosamide).

[150,151,152,153,154]